Caricamento...

Lurasidone: a novel antipsychotic agent for the treatment of schizophrenia and bipolar depression

Lurasidone is a novel antipsychotic agent approved for the treatment of schizophrenia in a number of countries including the UK, and is also approved in the USA and Canada for the treatment of major depressive episodes associated with bipolar I disorder as either a monotherapy or adjunctive therapy...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:BJPsych Bull
Autori principali: Loebel, Antony, Citrome, Leslie
Natura: Artigo
Lingua:Inglês
Pubblicazione: Royal College of Psychiatrists 2015
Soggetti:
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4706192/
https://ncbi.nlm.nih.gov/pubmed/26755968
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1192/pb.bp.114.048793
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !